REGISTER
Dr Linda Duska at ASCO 2025 -- MedJ Interview
Dr Linda Duska at ASCO 2025 -- MedJ Interview is presented here as a key issue in ASCO. It pulls together the main findings on ASCO, KEYNOTE-A18, linda and shows what they may mean for diagnosis, monitoring, prevention, or treatment.

MedJ takes you straight to ASCO 2025.

Professor Linda Duska from the University of Virginia School of Medicine enthusiastically shared the KEYNOTE-A18 study, redefining the first-line treatment standard for advanced cervical cancer.

0
0
Loading